Status:
COMPLETED
Euglyca Application in Children and Adolescents With Type 1 Diabetes Mellitus
Lead Sponsor:
Aristotle University Of Thessaloniki
Conditions:
Diabetes Mellitus, Type 1
Eligibility:
All Genders
6-18 years
Phase:
NA
Brief Summary
80 children and adolescents with Diabetes Mellitus Type 1 were enrolled in the study and were randomly assigned in the intervention group (Euglyca group) or in the control group. Patients in the Eugly...
Detailed Description
Children and adolescents with Diabetes Mellitus Type 1 (T1DM) who visited consecutively this clinic were asked to participate in the study if they owned an Android smartphone and were familiar with it...
Eligibility Criteria
Inclusion
- Children and adolescents with Diabetes Mellitus type 1.
- Treatment with multiple daily injections (MDI) or continuous subcutaneous insulin infusion (CSII)
- Satisfactory knowledge of the concept of carbohydrates and lipids counting
Exclusion
- Use of another medical application for diabetes in the previous 3 months;
- Lack of capacity of reading greek.
Key Trial Info
Start Date :
April 1 2017
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
September 1 2018
Estimated Enrollment :
80 Patients enrolled
Trial Details
Trial ID
NCT03763474
Start Date
April 1 2017
End Date
September 1 2018
Last Update
December 5 2018
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Endocrine Unit of 3rd Department of Pediatrics of Aristotle University of Thessaloniki, Hippokration General Hospital
Thessaloniki, Greece, 54642